Advertisement

Advertisement

LPCN Stock Latest News

Lipocine Updates Corporate Presentation for Investor Communications

Company AnnouncementsLipocine Updates Corporate Presentation for Investor Communications

LPCN Earnings this Week: How Will it Perform?

PremiumPre-Earnings

LPCN Earnings this Week: How Will it Perform?

3d ago

Lipocine Reshapes Board Leadership Amid Strategic Shift

PremiumCompany Announcements

Lipocine Reshapes Board Leadership Amid Strategic Shift

17d ago

Lipocine price target lowered to $6 from $11 at Alliance Global

PremiumThe Fly

Lipocine price target lowered to $6 from $11 at Alliance Global

25d ago

Lipocine downgraded to Neutral from Buy at H.C. Wainwright

PremiumThe Fly

Lipocine downgraded to Neutral from Buy at H.C. Wainwright

1M ago

Lipocine weighs path after LPCN 1154 Phase 3 miss

PremiumCompany AnnouncementsLipocine weighs path after LPCN 1154 Phase 3 miss

1M ago

Lipocine Updates Investor Presentation to Refine Market Messaging

Company Announcements

Lipocine Updates Investor Presentation to Refine Market Messaging

1M ago

Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial

The Fly

Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial

1M ago

Lipocine price target raised to $11 from $6.75 at Alliance Global

PremiumThe Fly

Lipocine price target raised to $11 from $6.75 at Alliance Global

2M ago

Lipocine Files Prospectus to Enable $50M Stock Offering

PremiumCompany Announcements

Lipocine Files Prospectus to Enable $50M Stock Offering

2M ago

LPCN Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

LPCN Upcoming Earnings Report: What to Expect?

2M ago

Lipocine Completes Phase 3 Trial for Postpartum Depression

PremiumCompany Announcements

Lipocine Completes Phase 3 Trial for Postpartum Depression

3M ago

Lipocine Updates Investor Presentation to Reflect Latest Strategy

PremiumCompany AnnouncementsLipocine Updates Investor Presentation to Reflect Latest Strategy

3M ago

Lipocine announces last patient visit in Phase 3 trial of LPCN 1154

The Fly

Lipocine announces last patient visit in Phase 3 trial of LPCN 1154

3M ago

Lipocine price target raised to $15 from $7 at H.C. Wainwright

The Fly

Lipocine price target raised to $15 from $7 at H.C. Wainwright

4M ago

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

PremiumCompany Announcements

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

4M ago

Lipocine completes enrollment, dosing in Phase 3 trial of LPCN 1154

PremiumThe Fly

Lipocine completes enrollment, dosing in Phase 3 trial of LPCN 1154

4M ago

Lipocine updates investor presentation and corporate materials

PremiumCompany Announcements

Lipocine updates investor presentation and corporate materials

4M ago

Lipocine Advances Phase 3 Postpartum Depression Drug Trial

PremiumCompany Announcements

Lipocine Advances Phase 3 Postpartum Depression Drug Trial

4M ago

Lipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned

PremiumThe FlyLipocine: DSMB recommended Phase 3 LPCN 1154 continue as planned

4M ago

Lipocine Advances Phase 3 Trial for PPD Treatment

Company Announcements

Lipocine Advances Phase 3 Trial for PPD Treatment

5M ago

Lipocine ‘s PPD Phase 3 study hits 80% enrollment milestone

The Fly

Lipocine ‘s PPD Phase 3 study hits 80% enrollment milestone

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >